423 related articles for article (PubMed ID: 27448990)
1. Effect of a genetically engineered bacteriophage on Enterococcus faecalis biofilms.
Tinoco JM; Buttaro B; Zhang H; Liss N; Sassone L; Stevens R
Arch Oral Biol; 2016 Nov; 71():80-86. PubMed ID: 27448990
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial effect of genetically-engineered bacteriophage ϕEf11/ϕFL1C(Δ36)P
Tinoco JM; Liss N; Zhang H; Nissan R; Gordon W; Tinoco E; Sassone L; Stevens R
Arch Oral Biol; 2017 Oct; 82():166-170. PubMed ID: 28646693
[TBL] [Abstract][Full Text] [Related]
3. Anti-biofilm Activity of a Lytic Phage Against Vancomycin-Resistant
Goodarzi F; Hallajzadeh M; Sholeh M; Talebi M; Pirhajati Mahabadi V; Amirmozafari N
Iran J Pathol; 2022; 17(3):285-293. PubMed ID: 36247507
[TBL] [Abstract][Full Text] [Related]
4. Targeting Enterococcus faecalis biofilms with phage therapy.
Khalifa L; Brosh Y; Gelman D; Coppenhagen-Glazer S; Beyth S; Poradosu-Cohen R; Que YA; Beyth N; Hazan R
Appl Environ Microbiol; 2015 Apr; 81(8):2696-705. PubMed ID: 25662974
[TBL] [Abstract][Full Text] [Related]
5. Phage-Bacteria Interactions in Potential Applications of Bacteriophage vB_EfaS-271 against
Topka-Bielecka G; Nejman-Faleńczyk B; Bloch S; Dydecka A; Necel A; Węgrzyn A; Węgrzyn G
Viruses; 2021 Feb; 13(2):. PubMed ID: 33669643
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Effects of Intravitreously Administered Bacteriophage in a Mouse Model of Endophthalmitis Caused by Vancomycin-Sensitive or -Resistant Enterococcus faecalis.
Kishimoto T; Ishida W; Fukuda K; Nakajima I; Suzuki T; Uchiyama J; Matsuzaki S; Todokoro D; Daibata M; Fukushima A
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451497
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomics Analysis Reveals Putative Genes Involved in Biofilm Formation and Biofilm-associated Drug Resistance of Enterococcus faecalis.
Seneviratne CJ; Suriyanarayanan T; Swarup S; Chia KHB; Nagarajan N; Zhang C
J Endod; 2017 Jun; 43(6):949-955. PubMed ID: 28457636
[TBL] [Abstract][Full Text] [Related]
8. Identification of Novel Bacteriophages with Therapeutic Potential That Target
Al-Zubidi M; Widziolek M; Court EK; Gains AF; Smith RE; Ansbro K; Alrafaie A; Evans C; Murdoch C; Mesnage S; Douglas CWI; Rawlinson A; Stafford GP
Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31451618
[TBL] [Abstract][Full Text] [Related]
9. Assessment of antibiotic resistance and biofilm formation of Enterococcus species isolated from different pig farm environments in Poland.
Grudlewska-Buda K; Skowron K; Bauza-Kaszewska J; Budzyńska A; Wiktorczyk-Kapischke N; Wilk M; Wujak M; Paluszak Z
BMC Microbiol; 2023 Mar; 23(1):89. PubMed ID: 36997857
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an
Song M; Wu D; Hu Y; Luo H; Li G
Front Cell Infect Microbiol; 2021; 11():698807. PubMed ID: 34336721
[No Abstract] [Full Text] [Related]
11. Cold plasma therapy of a tooth root canal infected with enterococcus faecalis biofilms in vitro.
Pan J; Sun K; Liang Y; Sun P; Yang X; Wang J; Zhang J; Zhu W; Fang J; Becker KH
J Endod; 2013 Jan; 39(1):105-10. PubMed ID: 23228267
[TBL] [Abstract][Full Text] [Related]
12. The lytic bacteriophage vB_EfaH_EF1TV, a new member of the Herelleviridae family, disrupts biofilm produced by Enterococcus faecalis clinical strains.
D'Andrea MM; Frezza D; Romano E; Marmo P; Henrici De Angelis L; Perini N; Thaller MC; Di Lallo G
J Glob Antimicrob Resist; 2020 Jun; 21():68-75. PubMed ID: 31678321
[TBL] [Abstract][Full Text] [Related]
13. Bacteriophage φEf11 ORF28 Endolysin, a Multifunctional Lytic Enzyme with Properties Distinct from All Other Identified Enterococcus faecalis Phage Endolysins.
Zhang H; Buttaro BA; Fouts DE; Sanjari S; Evans BS; Stevens RH
Appl Environ Microbiol; 2019 Jul; 85(13):. PubMed ID: 30979842
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a novel Enterococcus faecalis bacteriophage phiEF24C as a therapeutic candidate.
Uchiyama J; Rashel M; Maeda Y; Takemura I; Sugihara S; Akechi K; Muraoka A; Wakiguchi H; Matsuzaki S
FEMS Microbiol Lett; 2008 Jan; 278(2):200-6. PubMed ID: 18096017
[TBL] [Abstract][Full Text] [Related]
15. Bacteriophage Resistance Alters Antibiotic-Mediated Intestinal Expansion of Enterococci.
Chatterjee A; Johnson CN; Luong P; Hullahalli K; McBride SW; Schubert AM; Palmer KL; Carlson PE; Duerkop BA
Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30936157
[No Abstract] [Full Text] [Related]
16. Eradication of Vancomycin-Resistant Enterococci by Combining Phage and Vancomycin.
Shlezinger M; Coppenhagen-Glazer S; Gelman D; Beyth N; Hazan R
Viruses; 2019 Oct; 11(10):. PubMed ID: 31623253
[TBL] [Abstract][Full Text] [Related]
17. Comparison of
Oh HK; Hwang YJ; Hong HW; Myung H
Viruses; 2021 Mar; 13(3):. PubMed ID: 33800040
[No Abstract] [Full Text] [Related]
18. Enterococcus Phage vB_EfaS_HEf13 as an Anti-Biofilm Agent Against Enterococcus faecalis.
Lee D; Im J; Kim AR; Jun W; Yun CH; Han SH
J Microbiol; 2024 Jun; ():. PubMed ID: 38935316
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial properties of silver nanoparticles as a root canal irrigant against Enterococcus faecalis biofilm and infected dentinal tubules.
Rodrigues CT; de Andrade FB; de Vasconcelos LRSM; Midena RZ; Pereira TC; Kuga MC; Duarte MAH; Bernardineli N
Int Endod J; 2018 Aug; 51(8):901-911. PubMed ID: 29397005
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloprotease-1 inhibits and disrupts Enterococcus faecalis biofilms.
Kumar L; Cox CR; Sarkar SK
PLoS One; 2019; 14(1):e0210218. PubMed ID: 30633757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
